BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mahendiran D, Kumar RS, Viswanathan V, Velmurugan D, Rahiman AK. In vitro and in vivo anti-proliferative evaluation of bis(4′-(4-tolyl)-2,2′:6′,2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors. J Biol Inorg Chem 2017;22:1109-22. [DOI: 10.1007/s00775-017-1488-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Del Bello F, Pellei M, Bagnarelli L, Santini C, Giorgioni G, Piergentili A, Quaglia W, Battocchio C, Iucci G, Schiesaro I, Meneghini C, Venditti I, Ramanan N, De Franco M, Sgarbossa P, Marzano C, Gandin V. Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor Effects. Inorg Chem 2022. [PMID: 35285628 DOI: 10.1021/acs.inorgchem.1c03658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Jayathuna MA, Ahmed S, Kim YG, Gajendiran M, Kim K, Rahiman AK. Ferrocenylimine-based homoleptic metal(II) complexes: Theoretical, biocompatibility, in vitro anti-proliferative, and in silico molecular docking and pharmacokinetics studies. Journal of Molecular Structure 2022;1250:131905. [DOI: 10.1016/j.molstruc.2021.131905] [Reference Citation Analysis]
3 Musiol R, Malecki P, Pacholczyk M, Mularski J. Terpyridines as promising antitumor agents: an overview of their discovery and development. Expert Opin Drug Discov 2021;:1-13. [PMID: 34928186 DOI: 10.1080/17460441.2022.2017877] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Kuzderová G, Rendošová M, Gyepes R, Sovová S, Sabolová D, Vilková M, Olejníková P, Bačová I, Stokič S, Kello M, Vargová Z. Antimicrobial and Anticancer Application of Silver(I) Dipeptide Complexes. Molecules 2021;26:6335. [PMID: 34770744 DOI: 10.3390/molecules26216335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jain S, Bhar K, Bandyopadhayaya S, Singh VK, Mandal CC, Tapryal S, Sharma AK. Development, evaluation and effect of anionic co-ligand on the biological activity of benzothiazole derived copper(II) complexes. J Inorg Biochem 2020;210:111174. [PMID: 32652261 DOI: 10.1016/j.jinorgbio.2020.111174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pellei M, Bagnarelli L, Luciani L, Del Bello F, Giorgioni G, Piergentili A, Quaglia W, De Franco M, Gandin V, Marzano C, Santini C. Synthesis and Cytotoxic Activity Evaluation of New Cu(I) Complexes of Bis(pyrazol-1-yl) Acetate Ligands Functionalized with an NMDA Receptor Antagonist. Int J Mol Sci 2020;21:E2616. [PMID: 32283777 DOI: 10.3390/ijms21072616] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
7 Wang Q, Zhang Q, Luan S, Yang K, Zheng M, Li K, Chen L, Li H. Adapalene inhibits ovarian cancer ES-2 cells growth by targeting glutamic-oxaloacetic transaminase 1. Bioorganic Chemistry 2019;93:103315. [DOI: 10.1016/j.bioorg.2019.103315] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
8 Bharathi S, Mahendiran D, Kumar RS, Kim YG, Gajendiran M, Kim K, Rahiman AK. Biocompatibility, in Vitro Antiproliferative, and in Silico EGFR/VEGFR2 Studies of Heteroleptic Metal(II) Complexes of Thiosemicarbazones and Naproxen. Chem Res Toxicol 2019;32:1554-71. [PMID: 31241919 DOI: 10.1021/acs.chemrestox.9b00087] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
9 Pellei M, Gandin V, Marchiò L, Marzano C, Bagnarelli L, Santini C. Syntheses and Biological Studies of Cu(II) Complexes Bearing Bis(pyrazol-1-yl)- and Bis(triazol-1-yl)-acetato Heteroscorpionate Ligands. Molecules 2019;24:E1761. [PMID: 31067640 DOI: 10.3390/molecules24091761] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
10 Guo J, Gu X, Zheng M, Zhang Y, Chen L, Li H. Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenase. Bioorg Chem. 2019;87:16-22. [PMID: 30852233 DOI: 10.1016/j.bioorg.2019.02.037] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
11 Wang X, Pang FH, Huang L, Yang XP, Ma XL, Jiang CN, Li FY, Lei FH. Synthesis and Biological Evaluation of Novel Dehydroabietic Acid-Oxazolidinone Hybrids for Antitumor Properties. Int J Mol Sci 2018;19:E3116. [PMID: 30314336 DOI: 10.3390/ijms19103116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
12 Mahendiran D, Amuthakala S, Bhuvanesh NSP, Kumar RS, Rahiman AK. Copper complexes as prospective anticancer agents: in vitro and in vivo evaluation, selective targeting of cancer cells by DNA damage and S phase arrest. RSC Adv 2018;8:16973-90. [DOI: 10.1039/c8ra00954f] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
13 Morelli MB, Amantini C, Santoni G, Pellei M, Santini C, Cimarelli C, Marcantoni E, Petrini M, Del Bello F, Giorgioni G, Piergentili A, Quaglia W. Novel antitumor copper( ii ) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity. New J Chem 2018;42:11878-87. [DOI: 10.1039/c8nj01763h] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]